RS

Rashmi Sahay

Active Director Director DIN 08845978
DIN 08845978 First appointment Aug 2020 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value •••• Premium profile

About Rashmi Sahay

Data last updated:

Rashmi Sahay is a Director at Mastodon Pharmaceuticals Private Limited (since 2020). The company operates in Healthcare. Mastodon Pharmaceuticals Private Limited reported revenue of ₹26.3 Lakh (FY 2023).

DIN 08845978
Primary Designation Director
Industry Healthcare
First Appointment 24 Aug 2020
Oldest Company Age 6 yrs
Largest company Mastodon Pharmaceuticals Private Limited · ₹26.3 Lakh (FY 2023)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director24 Aug 20202020₹26.3 Lakh (FY 2023)Active

Board colleagues of Rashmi Sahay

NameDINCompanyDesignation
Kavita Nandan08845979Mastodon Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mastodon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rashmi Sahay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rashmi Sahay

Rashmi Sahay currently holds 1 directorship: Mastodon Pharmaceuticals Private Limited (Director, since 24 Aug 2020, revenue ₹26.3 Lakh (FY 2023)).

Rashmi Sahay was first appointed on 24 Aug 2020 as Director at Mastodon Pharmaceuticals Private Limited.

The current boards of Rashmi Sahay's companies include Kavita Nandan (Mastodon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available